How severe is CVE-2022-48222?

CVE-2022-48222 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2022-48222 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (3rd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-48222?

CVE-2022-48222 affects Gbgplc Acuant Acufill Sdk. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2022-48222?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2022-48222 published?

CVE-2022-48222 was published on 2023-04-04 and last updated on 2026-06-17.

CVE-2022-48222

CVE-2022-48222 is a high-severity vulnerability in Gbgplc Acuant Acufill Sdk with a CVSS 3.x base score of 7.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-427.

Key facts

Severity: High (CVSS 3.x base score 7.8)
EPSS exploit prediction: 0% (3rd percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-427
Affected product: Gbgplc Acuant Acufill Sdk
Published: 2023-04-04
Last modified: 2026-06-17

Description

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During SDK installation, certutil.exe is called by the Acuant installer to install certificates. This window is not hidden, and is running with elevated privileges. A standard user can break out of this window, obtaining a full SYSTEM command prompt window. This results in complete compromise via arbitrary SYSTEM code execution (elevation of privileges).

Frequently asked questions

What is CVE-2022-48222?: An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During SDK installation, certutil.exe is called by the Acuant installer to install certificates. This window is not hidden, and is running with elevated privileges. A standard user can break out of this window, obtaining a full SYSTEM command prompt window. This results in complete compromise via arbitrary SYSTEM code execution (elevation of privileges).
How severe is CVE-2022-48222?: CVE-2022-48222 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-48222 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (3rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-48222?: CVE-2022-48222 affects Gbgplc Acuant Acufill Sdk. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-48222?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-48222 published?: CVE-2022-48222 was published on 2023-04-04 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:gbgplc:acuant_acufill_sdk:*:*:*:*:*:*:*:*

More vulnerabilities in Gbgplc Acuant Acufill Sdk

CVE-2022-48226 — High (CVSS 7.8): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of…
CVE-2022-48221 — High (CVSS 7.5): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user…
CVE-2022-48224 — High (CVSS 7.3): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is installed with insecure permissions (full write…
CVE-2022-48225 — High (CVSS 7.3): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is used to install drivers from several different…
CVE-2022-48223 — Medium (CVSS 6.7): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During SDK repair, certutil.exe is called by the…

All CVEs affecting Gbgplc Acuant Acufill Sdk →

Other CWE-427 (Uncontrolled Search Path Element) vulnerabilities

CVE-2025-4981 — Critical (CVSS 9.9): Mattermost versions 10.5.x <= 10.5.5, 9.11.x <= 9.11.15, 10.8.x <= 10.8.0, 10.7.x <= 10.7.2, 10.6.x <= 10.6.5 fail to…
CVE-2025-69599 — Critical (CVSS 9.8): RayVentory Scan Engine through 12.6 Update 8 allows attackers to gain privileges if they control the value of the PATH…
CVE-2019-25268 — Critical (CVSS 9.8): NREL BEopt 2.8.0.0 contains a DLL hijacking vulnerability that allows attackers to load arbitrary libraries by tricking…
CVE-2023-53959 — Critical (CVSS 9.8): FileZilla Client 3.63.1 contains a DLL hijacking vulnerability that allows attackers to execute malicious code by…
CVE-2025-65741 — Critical (CVSS 9.8): Sublime Text 3 Build 3208 or prior for MacOS is vulnerable to Dylib Injection. An attacker could compile a .dylib file…
CVE-2024-23054 — Critical (CVSS 9.8): An issue in Plone Docker Official Image 5.2.13 (5221) open-source software that could allow for remote code execution…

Browse all CWE-427 (Uncontrolled Search Path Element) vulnerabilities →